Enumeral Biomedical Taps Kevin Sarney, CPA as VP of Finance and Chief Accounting Officer
Proquest LLC |
In its release, the Company said that Sarney brings significant finance, accounting, operations and
"Kevin's experiences working with biotechnology companies developing targeted therapies, including antibodies, are directly relevant to Enumeral's platform and business goals," said
"As Enumeral is a newly public company with a technology broadly applicable across the rapidly changing immunotherapy space, this is an exciting time to join the organization," added Sarney. "I look forward to working with this innovative team and contributing to the company's value creation and execution of its business and program goals."
Prior to joining Enumeral, Sarney served as Vice President, Finance and Administration at Avaxia Biologics, a clinical-stage biopharmaceutical company developing gut-targeted therapeutics. Before Avaxia, he worked with various biotechnology and medical device companies in Vice President of Finance and Controller roles, having been the Corporate Controller and Principal Accounting Officer of
More Information and Complete Details:
((Comments on this story may be sent to [email protected]))
Copyright: | (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |
Wordcount: | 281 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News